Evaxion reports 86% precision rate for AI cancer vaccine platform

April 17, 2026 3:10 PM

Evaxion A/S (NASDAQ: EVAX) announced that its AI-Immunology platform achieved an 86% success rate in identifying vaccine targets that trigger ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found